![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/regarding-rumors-of-an-imminent-approval-of-lecanemab-in-great-britain-bioarctic-302228382.html
https://www.reuters.com/business/healthcare-pharmaceuticals/uk-patients-unlikely-get-access-eisai-biogens-alzheimers-drug-2024-08-22/
https://www.fiercepharma.com/pharma/biogen-sued-alleged-pbm-kickbacks-scheme-boost-tecfidera-sales-wake-generic-competition
https://www.reuters.com/business/healthcare-pharmaceuticals/incytes-blood-cancer-drug-succeeds-late-stage-trial-2024-08-15/
https://www.fiercebiotech.com/biotech/metagenomi-axes-als-program-after-seeing-biogen-and-ionis-flounder
https://www.prnewswire.com/news-releases/immunic-inc-reports-second-quarter-2024-financial-results-and-provides-corporate-update-302216567.html
https://www.fiercebiotech.com/biotech/sangamo-secures-50m-upfront-neurodegenerative-pact-genentech
https://www.fiercebiotech.com/biotech/sangamo-secures-50m-upfront-neurodegenerative-pact-genentech
https://www.fiercepharma.com/pharma/biogen-retains-biosimilars-eisai-partnered-leqembi-ploughs-ahead-amid-business-pivot
https://www.reuters.com/business/healthcare-pharmaceuticals/biogen-lifts-2024-profit-forecast-hopes-new-product-launches-2024-08-01/